Sutro Biopharma, Inc.

STRONASDAQHealthcareBiotechnology

$10.94- (-)1Y +13.47%

As of Oct 16, 2026 close

Market cap: $189.91M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $7.15$43.85
Volume (live): -
Avg. volume (3M): 336.63K

Sutro Biopharma, Inc. (STRO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Sutro Biopharma, Inc. stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Buy

Based on 9 unique analysts

(11 total ratings in last 90 days)

Medium Confidence8.0:1 Buy/Sell

Average Price Target

$51.17

+367.73% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest STRO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 1, 2026	Lukas Shumway	Barclays	Maintains	Buy	$56.00
Sep 30, 2026	Yanan Zhu	Wells Fargo	Maintains	Buy	$49.00
Sep 21, 2026	Andres Y. Maldonado	HC Wainwright	Maintains	Buy	$50.00
Aug 17, 2026	Laura Prendergast	Stifel Nicolaus	Maintains	Buy	$48.00
Aug 14, 2026	Tazeen Ahmad	BofA Securities	Maintains	Sell	-
Aug 13, 2026	Supawat Thongthip	Truist	Reiterates	Buy	$50.00
Aug 13, 2026	Tara Bancroft	TD Cowen	Maintains	Buy	-
Aug 13, 2026	Lukas Shumway	Barclays	Maintains	Buy	$56.00
Aug 12, 2026	Charles Zhu	LifeSci Capital	Maintains	Buy	$54.00
Aug 12, 2026	Tara Bancroft	TD Cowen	Maintains	Buy	-
Aug 12, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-

Lukas Shumway

Barclays

BuyMaintains

$56.00

Oct 1

Yanan Zhu

Wells Fargo

BuyMaintains

$49.00

Sep 30

Andres Y. Maldonado

HC Wainwright

BuyMaintains

$50.00

Sep 21

Laura Prendergast

Stifel Nicolaus

BuyMaintains

$48.00

Aug 17

Tazeen Ahmad

BofA Securities

SellMaintains

Aug 14

Supawat Thongthip

Truist

BuyReiterates

$50.00

Aug 13

Tara Bancroft

TD Cowen

BuyMaintains

Aug 13

Lukas Shumway

Barclays

BuyMaintains

$56.00

Aug 13

Charles Zhu

LifeSci Capital

BuyMaintains

$54.00

Aug 12

Tara Bancroft

TD Cowen

BuyMaintains

Aug 12

Zacks Equity Research

BuyInitiates Coverage

Aug 12

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 1, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for STRO?

The analyst consensus rating for STRO is Buy, based on the latest ratings from 9 analysts over the last 90 days.

What is the average price target for STRO?

The average 12-month price target for STRO is $51.17, representing an upside of 367.7% from the Oct 16, 2026 close of $10.94.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.